Sun Pharma Labs. Ltd.’s Software Upgradation Expenses classified as Revenue Expenditure: ITAT upholds CIT(A) Ruling [Read Order]
This classification, totaling ₹1,49,62,413, allows the company to claim immediate deductions under the Income Tax Act, 1961, treating these costs—related to data migration, online support, and routine maintenance—as operational rather than capital expenses
The Ahmedabad Bench of Income Tax Appellate Tribunal ( ITAT ) upheld the Commissioner of Income Tax (Appeals) [CIT(A)] ruling regarding Sun Pharma Laboratories Ltd.’s software upgradation expenses, classifying them as revenue expenditures. The revenue-appellant contested the CIT(A) order dated 28.02.2019 concerning the assessment for Assessment year(AY) 2015-16 under Section 143(3) of the Income Tax…
Your free access to Taxscan has Expired
To read the article, get a premium account.
Taxscan Premium
Why should you subscribe?
Enjoy our website without interruptions from advertisements
Receive Daily newsletters
Receive realtime Telegram/Whatsapp news updates
Download original Judgements / Order / Notifications / Circulars, etc
